Linda Thorén

4PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 02, 2025
CYP2D6 genotype and outcome in tamoxifen treated early breast cancer.

Linda Thorén, Jonatan D Lindh, Espen Molden

|Mar 01, 2023
Adherence to endocrine therapy in early breast cancer in relation to Cytochrome P450 2D6 genotype: a comparison between pharmacy dispensation data and medical records.

Linda Thorén, Sara Margolin, Erik Eliasson

|Sep 27, 2021
Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients.

Linda Thorén, Mikael Eriksson, Jonatan D Lindh

|Jul 27, 2020
Impairment of endoxifen formation in tamoxifen-treated premenopausal breast cancer patients carrying reduced-function CYP2D6 alleles.

Linda Thorén, Jonatan D Lindh, Gerd Ackehed

Pageof 1

Frequent Collaborators

2 joint publications

Espen Molden

1 joint publications

Jonatan D Lindh

1 joint publications

Marianne Kristiansen Kringen

1 joint publications

Jonas Bergh